No menu items!

Tag: The serum is a concentrate of antibodies against the novel coronavirus and can be administered as soon as patients display clinical symptoms of the disease

RIO DE JANEIRO, BRAZIL - The Brazilian Health Regulatory Agency (ANVISA) on Tuesday, May 25, authorized the start of trials of the anti-Sars-CoV-2 serum, developed by the Butantan Institute, in São Paulo. With the decision, the Butantan Institute may begin...

LATEST NEWS

WEATHER

Rio de Janeiro
mist
18 ° C
18.9 °
18 °
98 %
4.6kmh
100 %
Fri
20 °
Sat
23 °
Sun
23 °
Mon
21 °
Tue
19 °